Actively Recruiting
Acute Amino Acid Response of Proprietary Beverages
Led by Shaklee Corporation · Updated on 2026-04-23
24
Participants Needed
2
Research Sites
4 weeks
Total Duration
On this page
Sponsors
S
Shaklee Corporation
Lead Sponsor
B
Biofortis Clinical Research, Inc.
Collaborating Sponsor
AI-Summary
What this Trial Is About
The primary objective of this study is to evaluate post-meal amino acid in response to a proprietary beverages in generally healthy adults.
CONDITIONS
Official Title
Acute Amino Acid Response of Proprietary Beverages
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Males and females aged 20 to 50 years
- Body mass index between 18.5 and less than 25.0 kg/m2
- Regular breakfast consumers at least 5 days per week
- Women who are pre- or post-menopausal; premenopausal women not using hormonal contraceptives must have regular menstrual cycles (21-35 days) for at least 3 months prior
- Willing and able to use a personal smartphone and download the Cronometer app for diet records
- Willing to follow all study procedures and provide informed consent
You will not qualify if you...
- Currently following or planning a weight loss regimen before or during the study
- Weight change greater than 4.5 kg within 90 days
- History of gastrointestinal surgery for weight reduction
- History of eating disorders or extreme dietary habits such as ketogenic, very high protein, very high fiber, vegan, or vegetarian diets
- History of unconventional sleep patterns, diagnosed sleep disorders, or chronic medical conditions affecting appetite
- Use of tobacco or nicotine products within 12 months
- Use of hemp or marijuana products within 60 days except occasional use (once or twice a month)
- Unstable use of prescription medications within 90 days
- Initiation or dose change in hormonal contraceptives within 30 days
- Use of dietary supplements other than a daily multivitamin/mineral
- History or strong potential for alcohol or substance abuse within 12 months
- Exposure to any non-registered drug product within 30 days
- Vein Access Scale Assessment score less than 7
- History or presence of significant cardiac, renal, hepatic, endocrine, pulmonary, gastrointestinal, biliary, pancreatic, or neurological disorders
- Uncontrolled hypertension (systolic ≥160 mm Hg or diastolic ≥100 mm Hg)
- Known allergy to ingredients in study products or foods
- Signs or symptoms of active infection within 5 days
- History of cancer within 2 years except nonmelanoma skin cancer
- Major trauma or surgery within 2 months
- Pregnant, planning pregnancy, lactating, or unstable use of sex hormones for contraception
- Financial interest in Shaklee Corporation
- Any condition interfering with informed consent or study compliance as judged by the Investigator
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 2 locations
1
Biofortis Clinical Research
Addison, Illinois, United States, 60101
Not Yet Recruiting
2
Biofortis Clinical Research
Addison, Illinois, United States, 60101
Actively Recruiting
Research Team
B
Biofortis Clinical Research Clinical Director
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
DOUBLE
Allocation
RANDOMIZED
Model
CROSSOVER
Primary Purpose
OTHER
Number of Arms
4
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here